Safe, inexpensive, and well-tolerated
The alarming worldwide increase in obesity requires the development of new molecules that increase patient compliance by reducing the frequency of administration, facilitating intake, and reducing the adverse effects of treatments
Duration of treatment Most weight management protocols recommend continuing semaglutide for at least 12-18 months to reach full weight loss potential
However, newer GLP-1 medications, such as tirzepatide, which target both GLP-1 and GIP receptors, may be even more effective for weight loss
Its primary pathological features include inflammatory infiltration and tissue damage of the gastric mucosa
Yaplan aratrmalar glutatyon kemoterapinin zararl etkisinin azaltabileceini ve tedaviye destek olabileceini gstermekte (9)